Manik Baltaian

Title: The Innovations of Manik Baltaian

Introduction

Manik Baltaian is a notable inventor based in Glendale, CA. He has made significant contributions to the field of biotechnology, particularly in the development of novel bactericidal proteins. With a total of 5 patents to his name, Baltaian's work has the potential to impact the treatment of bacterial infections.

Latest Patents

One of Baltaian's latest patents focuses on stable bactericidal/permeability-increasing protein products. This patent discloses novel BPI protein products where cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably alanine or serine. Additionally, it addresses the leucine residue at position 193 being the carboxy terminal residue. The patent also includes DNA sequences encoding methods for the production of these proteins in appropriate host cells, along with stable homogeneous pharmaceutical compositions suitable for treating gram-negative bacterial infections and their sequelae.

Career Highlights

Baltaian is currently employed at Xoma Corporation, where he continues to innovate in the field of pharmaceuticals. His work at Xoma Corporation has allowed him to explore the therapeutic applications of his inventions, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Baltaian has collaborated with notable colleagues, including Georgia Theofan and Arnold H Horwitz. These collaborations have likely enriched his research and development efforts, fostering a productive environment for innovation.

Conclusion

Manik Baltaian's contributions to biotechnology and his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatments for bacterial infections, showcasing the importance of innovation in healthcare.